Our Mission
PeopleBeatingCancer supports an evidence-based integrative approach to cancer care. For most newly diagnosed patients, FDA-approved therapies form the foundation of treatment, while evidence-based complementary therapies may help reduce side effects and improve survivorship.
Click the orange button to the right to learn more.
- You are here:
- Home »
- Blog »
- non-conventional therapies »
- Multiple Myeloma Therapy- The Greek Test & The “miracle cure” Vet Medicine
Multiple Myeloma Therapy- The Greek Test & The “miracle cure” Vet Medicine
we cancer patients just don’t know much about untested “miracle cure” therapies. Also, I’m suspect of anything that is called a “miracle cure.” I’m cynical that way…
David: Have you ever heard of the “Greek Test?” According to Dr. Forsythe I took this test and it came up with the protocol (possible multiple myeloma therapy) in the front of the Greek test. Ever heard of it? Also an article he gave me about some kind of a vet medicine that’s a “miracle cure” Don’t want to be a fool but any thoughts? Dick
Hi Dick-
MM CC members frequently ask me about little known MM therapies and tests. There is a lot of information out there when it comes to treating cancer in general and MM specifically.
I have heard of the Greek Test but know little about it. My understanding is that the test you are referring to is discussed at the link below.
Regarding your question about “vet medicine,” yes, I have heard of, read a bit about, this medicine. Info is linked below.
Your challenge is to undergo tests/therapies that have not been researched, tested, etc. as fully as conventional tests, therapies have been. While these tests/therapies may be helpful, you have no way of knowing-
- if the drugs have side effects
- what those side effects may be
going into them. Though conventional FDA approved cancer therapies also have side effects, these therapies are more fully understood.
I have to be honest and admit that I knew little about the Burzynski Clinic/ANP when I began this multiple myeloma therapy in late ’97. But there were many research articles written about ANP and I did have basic understanding of toxicity, side effects, efficacy, etc.
We MM survivors can feel desperate if we are end-stage. I was end-stage. I was desperate…
Let me be clear. The “miracle cure” vet medicine that you’re asking about may, in fact, kill cancer. The article linked and excerpted below cites thousands of previously untested compounds that kill cancer.
My point is, we cancer patients just don’t know much about untested “miracle cure” therapies. Also, I’m suspect of anything that is called a “miracle cure.” I’m cynical that way…
However, if you have other therapy options currently, even if they are not curative but simply buy you time (put you in remission), I myself, would do these first, before I did untested therapies.
This is just my opinion. Let me know if you have any questions.
Hang in there,
David Emerson
- MM Survivor
- MM Coach
- Director PeopleBeatingCancer
Recommended Reading:
- Multiple Myeloma Pain Management- Cannabinoids, C-B-D
- Multiple Myeloma Therapies- Best of Both Conventional, Non-Conventional
- Multiple Myeloma Chemotherapy- Preventing MM Relapse, Curing MM?
Dozens of non-oncology drugs can kill cancer cells
“Researchers tested approximately 4,518 drug compounds on 578 human cancer cell lines and found nearly 50 that have previously unrecognized anti-cancer activity. These drugs have been used to treat conditions such as diabetes, inflammation, alcoholism, and even arthritis in dogs. The findings suggest a possible way to accelerate the development of new cancer drugs or repurpose existing drugs to treat cancer…
It is the largest study yet to employ the Broad’s Drug Repurposing Hub, a collection that currently comprises more than 6,000 existing drugs and compounds that are either FDA-approved or have been proven safe in clinical trials (at the time of the study, the Hub contained 4,518 drugs)…
The researchers hope to study the repurposing library compounds in more cancer cell lines and to grow the hub to include even more compounds that have been tested in humans. The team will also continue to analyze the trove of data from this study, which have been shared openly (https://depmap.org) with the scientific community, to better understand what’s driving the compounds’ selective activity…”